Mark Collins Email & Phone Number

At Undaunted Bio we take a unique clinically informed, network-medicine approach to repurposing existing drugs for acute and chronic neuropathic pain. Our initial focus is on less common neuropathic pain conditions such as Trigeminal Neuralgia, Post-herpetic pain, and Chemo-induced neuropathy.Undaunted Bio is a new startup and I am leading the scientific and translational approach to repurposing our first drug, UDB412 for trigeminal neuralgia.

Leuven, Be

icometrix (Leuven, Belgium. Boston, USA) is a leader in AI-based digital health tools for neurological disease care and therapy development with a focus on the patient. Our FDA/CE cleared icobrain MRI analysis software and CE marked icompanion app are helping to transform the care of patients with Multiple Sclerosis, Traumatic Brain Injury, Epilepsy, Alzheimer’s Disease, Stroke, etc.Together with our Pharma partners we are de-risking clinical translation for neurological therapies through innovative patient-oriented AI-driven approaches that impact the development of new therapies and the clinical success of existing therapies.

Pittsburgh, Pennsylvania, Us

Reporting to the CEO, I am responsible for the delivery and commercialization of our AI-driven predictive model of cancer. These models are used by Pharmaceutical companies to develop the next generation of targeted therapies for cancer and once validated will be used for clinical decision support, to help clinicians individualize therapies to improve outcomes for patients. To learn more visit www.helomics.com

Pittsburgh, Pennsylvania, Us

Reporting to the CEO I am responsible for transforming and restructuring the Helomics' product and service portfolio to deliver sustainable commercial success in the rapidly growing precision medicine marketplace.Leading the development of rigorous strategic and economic business cases for all existing/new Helomics products/services offerings, including customer needs, revenue, P&L and market share targets.Building and leading the development of Helomics' D-CHIP Artificial Intelligence platform, which leverages Helomics unique database of genomic, clinical and drug response profiles from 150,000 anonymized cancer cases. Acting as an “evangelist” for Helomics through engagement with KOL’s, prospects and thought leadership.

Basel, Ch

Acted as a "product evangelist" for omics based patient profiling in clinical and translational researchDeveloped and executing on go-to-market strategiesInternal subject matter expert on omics in clinical and translational researchDeveloped strategic business relationships and partnerships in North America

• Developed the technology strategy to drive the business strategy of the company• Developed a Software-as-a service platform for global specimen and data tracking (GlobalCODE(tm) and snapTRACK(tm) in 10 months with a small in house team and external developer resources• Built and coached the internal/external development team• Acted as an technology evangelist for the company to support business development activities• Oversaw two software audits for use of GlobalCODE in a validated environment• Filed 3 patents for consent codification and tracking, mobile specimen tracking as well as an innovative approach to securing the privacy of patient data

Basel, Ch

• Developed go-to-market strategies for their imaging software platform, including development strategy, KOLs, competitors and field-marketing/sales enablement.• Developed go-to-market strategies for a new translational research product, Genedata Profiler, including high level technical requirements, user persona research, competitors and sales enablement.

Columbia, Md, Us

Reporting to the CEO, I am leading market strategy and tactical marketing for BioFortis' biobanking, translational research biomarker and clinical study informatics platform.

Built a thriving life science marketing consultancy, offering market, product and marketing strategy consulting as well as tactical execution.• Reporting to the CEO, developed go-to-market strategies for several small life-science imaging companies• Executed e-marketing campaigns to drive thought leadership for companies• Mentored key staff on product development processes• Undertook strategic market and business reviews for several small companies in the cell analysis and clinical informatics space

Waltham, Ma, Us

Led the development and execution of the marketing and product line strategy for a global cell sciences business, comprising instrumentation, software, consumables and reagents. Directed a product marketing and management team of nine, with P&L accountability.

Waltham, Ma, Us

Working with Thermo senior leaders developed a strategy for a vertically integrated business unit to focus Thermo Fisher on cell biology market. Incorporated VOC, market data and financial models working closely.Developed a team of product and market segment managers plus marcom to deliver marketing for the cell imaging product line.Successfully launched a new application focused solution for in vitro Toxicity testing (ToxInsight) with impact in the drug discovery and consumer product testing market.Improved sales administration through use of Sharepoint and SFDC.

Waltham, Ma, Us

Continued to successfully drive the market strategy for HCS, developing innovative marketing strategies resulting in continued double-digit sales growth and maintaining Thermo as #1 in the HCS marketplace. Thermo was the winner of the 2007 Frost & Sullivan Award for Market leadership in HCS.Initiated an innovative “blue-ocean” strategy to develop imaging as an enabler in the in vitro toxicology marketplace. Working closely with sales, created novel pricing strategies to drive a 40% increase in sales vs. PY

Us

Introduced focus groups and VOC as well as Agile techniques to successfully commercialise and bring to market several innovative informatics products, resulting in revenues of $3.5M+ annually.Successfully developed the strategy to position informatics products for high content screening (HCS) as a key competitive differentiator.Drove business development with key partners (Spotfire, EMC and IBM) to deliver new products and internal services. Responsible for Cellomics’ web based Bioinformatics products, developing e-commerce software delivery and SaaS

Co founded MHC as a provider of Discovery Informatics and Knowledge based drug discovery solutions.Solely responsible for technical direction of the company, building a team of 6 software developers and designing and commercialising multiple products.Grew the business (without external investment) to $750,000 p.a revenues.Successfully sold the business to Cellomics Inc in February 2001.Three patents awarded in the drug discovery/knowledge mining/novel cheminformatics area

Ingelheim Am Rhein, Rhineland-Palatinate, De

Overall responsibility for designing, developing and implementing Vienna’s IT strategy to meet the R&D goals, (genomics to lead optimisation), reporting at board level both locally and internationally. Responsible for an internal staff of 4, plus 3 external contractors and a budget of $1M+.

Wide-ranging role to develop and commercialize the use of Artificial Intelligence in the Pharmaceutical sector.Managed the successful design, development, release and marketing data mining tool-the product, NeuFrame, with a user base of 5000 world-wide.Managed the product team (6 developers, plus 2 support and 2 sales)Managed 3 European projects in the field of AI for Smart cards, electronic sensors and industrial control.

Set up a (profitable) consultancy business, specialising in the areas of Artificial Intelligence and Neural Networks applied to the Pharmaceutical Industry. Consulted on a wide range of projects in both the food, pharmaceutical and business sectors, ranging from technology audits through to design of software and hardware.Technical Expert to the Welsh Development Agency on BioInformatics

Early recruit to the company and played a played a vital role in the establishment of the Applied Microbiology Department, rapidly establishing infrastructure to facilitate the isolation and fermentation of >2500 micro-organisms per year.Company-wide responsibility for the development, implementation and management of in-house computer systems and designed systems for the tracking of active compounds from micro-organism to chemical structure.Managed a staff of 8 taking overall responsibility for project management and budgeting ($500K)

Managed a multidisciplinary project investigating microbiological safety assessment of the burial of low level nuclear waste in shallow ground repositories for UK NIREX.

Doctor Of Philosophy (Ph.D.), Microbiology, General

Bachelor'S Degree (Bsc), Applied Science, Microbiology, Computing